IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 41 filers reported holding IMMUNE DESIGN CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 3.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $49,000 | +308.3% | 8,412 | -6.8% | 0.00% | – |
Q4 2018 | $12,000 | -62.5% | 9,028 | -2.7% | 0.00% | – |
Q3 2018 | $32,000 | +6.7% | 9,281 | +42.0% | 0.00% | – |
Q2 2018 | $30,000 | +76.5% | 6,537 | +24.4% | 0.00% | – |
Q1 2018 | $17,000 | -5.6% | 5,253 | +15.2% | 0.00% | – |
Q4 2017 | $18,000 | – | 4,558 | +14603.2% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 31 | -72.8% | 0.00% | – |
Q2 2017 | $1,000 | 0.0% | 114 | -11.6% | 0.00% | – |
Q1 2017 | $1,000 | – | 129 | +1190.0% | 0.00% | – |
Q4 2016 | $0 | -100.0% | 10 | -95.3% | 0.00% | – |
Q2 2016 | $2,000 | -98.1% | 215 | -97.3% | 0.00% | – |
Q1 2016 | $103,000 | +12.0% | 7,944 | +74.2% | 0.00% | – |
Q4 2015 | $92,000 | – | 4,561 | +227950.0% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 2 | -98.7% | 0.00% | – |
Q2 2015 | $3,000 | -57.1% | 152 | -54.2% | 0.00% | – |
Q1 2015 | $7,000 | -78.1% | 332 | -68.2% | 0.00% | – |
Q4 2014 | $32,000 | +700.0% | 1,044 | +392.5% | 0.00% | – |
Q3 2014 | $4,000 | – | 212 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
Abingworth LLP | 352,300 | $458,000 | 0.42% |
Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |